John W. Hubbard's most recent trade in Science 37 Holdings Inc was a trade of 24,742 Restricted Stock Units done . Disclosure was reported to the exchange on March 12, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Science 37 Holdings Inc | John W. Hubbard | Former Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Mar 2024 | 24,742 | 0 | - | - | Restricted Stock Units | |
| Science 37 Holdings Inc | John W. Hubbard | Former Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Mar 2024 | 20,195 | 0 | - | - | Stock Option | |
| Science 37 Holdings Inc | John W. Hubbard | Former Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Mar 2024 | 2,540 | 0 | - | - | Earn-Out Right | |
| Science 37 Holdings Inc | John W. Hubbard | Former Director | 12 Mar 2024 | 2,050 | 0 | - | 5.8 | 11,788 | Common Stock | |
| Science 37 Holdings Inc | John W. Hubbard | Former Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Mar 2024 | 1,378 | 0 | - | - | Stock Option | |
| Agile Therapeutics Inc | John W. Hubbard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 1,065 | 1,065 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | John W. Hubbard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 935 | 976 (0%) | 0% | 0 | Common Stock | |
| Science 37 Holdings Inc | John W. Hubbard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 494,853 | 494,853 | - | - | Restricted Stock Units | |
| Science 37 Holdings Inc | John W. Hubbard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 40,983 | 40,983 | - | 0 | Common Stock | |
| Science 37 Holdings Inc | John W. Hubbard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 40,983 | 0 | - | - | Restricted Stock Units | |
| Agile Therapeutics Inc | John W. Hubbard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 807 | 807 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | John W. Hubbard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 670 | 2,066 (0%) | 0% | 0 | Common Stock | |
| Science 37 Holdings Inc | John W. Hubbard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 40,983 | 40,983 | - | - | Restricted Stock Units | |
| Science 37 Holdings Inc | John W. Hubbard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2021 | 403,896 | 403,896 | - | - | Stock Option | |
| Science 37 Holdings Inc | John W. Hubbard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2021 | 50,802 | 50,802 | - | - | Earn-Out Right | |
| Science 37 Holdings Inc | John W. Hubbard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2021 | 27,575 | 27,575 | - | - | Stock Option | |
| Agile Therapeutics Inc | John W. Hubbard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 29,905 | 29,905 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | John W. Hubbard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 24,510 | 55,852 (0%) | 0% | 0 | Common Stock |